Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-17.6%
5Y CAGR+0.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-17.6%/yr
vs +12.1%/yr prior
5Y CAGR
+0.2%/yr
Recent deceleration
Acceleration
-29.7pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $35.01M | -41.8% |
| 2024 | $60.12M | +40.5% |
| 2023 | $42.79M | -31.7% |
| 2022 | $62.68M | +11.5% |
| 2021 | $56.22M | +62.4% |
| 2020 | $34.61M | -38.8% |
| 2019 | $56.51M | +42.3% |
| 2018 | $39.70M | +76.5% |
| 2017 | $22.49M | +20.3% |
| 2016 | $18.70M | - |